Vir Biotechnology (VIR) Return on Sales (2018 - 2026)
Vir Biotechnology (VIR) reported Return on Sales of 43.34% for Q1 2026, down 4294.0% on a YoY basis from 1.03% in Q1 2025, and down 646870.77% sequentially from 0.01% in Q4 2025.
Vir Biotechnology (VIR) Return on Sales (2018 - 2026) Analysis & Trends
Vir Biotechnology (VIR) has 9 years of Return on Sales data on file, last reported at 43.34% in Q1 2026.
- For the quarter ending Q1 2026, Return on Sales fell 4294.0% year-over-year to 43.34%; the trailing twelve-month figure through Mar 2026 stood at 0.07% (up 21.0% YoY), and the FY2025 full-year result was 0.06%, up 1.0% from the prior year.
- Return on Sales retreated to 43.34% in Q1 2026, from 0.01% in the prior quarter.
- In the past five years, Return on Sales ranged from a high of 0.0% in Q3 2022 to a low of 43.34% in Q1 2026.
- A 5-year average of 3.19% and a median of 0.08% in 2024 frame the typical range for Return on Sales.
- Across the five-year window, Return on Sales soared 86 bps in 2022 and sank 4294 bps in 2026, its largest moves.
- Tracing VIR's Return on Sales over 5 years: stood at 0.02% in 2022, then slumped by 236 bps to 0.07% in 2023, then fell by 22 bps to 0.08% in 2024, then soared by 92 bps to 0.01% in 2025, then slumped by 646871 bps to 43.34% in 2026.
- Business Quant data shows VIR's Return on Sales at 43.34% in Q1 2026, 0.01% in Q4 2025, and 6.8% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.00% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 0.00% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 0.00% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 0.00% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Vir Biotechnology | 1.38 Bn | 1.38 Bn | - | -43.34% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -43.34% |
| Dec 31, 2025 | -0.01% |
| Sep 30, 2025 | -6.80% |
| Jun 30, 2025 | -0.91% |
| Mar 31, 2025 | -0.40% |
| Dec 31, 2024 | -0.08% |
| Sep 30, 2024 | -0.90% |
| Jun 30, 2024 | -0.45% |
| Mar 31, 2024 | -0.01% |
| Dec 31, 2023 | -0.07% |
| Sep 30, 2023 | -0.62% |
| Jun 30, 2023 | -0.51% |
| Mar 31, 2023 | -0.02% |
| Dec 31, 2022 | -0.02% |
| Sep 30, 2022 | 0.00% |
| Jun 30, 2022 | -0.02% |
| Mar 31, 2022 | 0.00% |
| Dec 31, 2021 | 0.01% |
| Sep 30, 2021 | 0.01% |
| Jun 30, 2021 | 0.00% |